Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Analysts Believe Madrigal's Resmetirom Shows Impressive Overall Profile In Liver Fibrosis

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) presented multiple resmetirom abstracts at the European Association for the Study of the Liver's International Liver Congress. The data included new details on changes in FibroScan controlled attenuation parameter and liver stiffness measurement along with magnetic resonance elastography, which serves as critical non-invasive measures of liver stiffness and fibrosis. …

Nasdaq Drops 75 Points; Acutus Medical Shares Spike Higher

Nasdaq Drops 75 Points; Acutus Medical Shares Spike Higher

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 75 points on Monday.

Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday

During Monday's session, 77 companies made new 52-week lows.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.

Short Volatility Alert: Airgain, Inc.

On Friday, shares of Legend Airgain, Inc. (NASDAQ: AIRG) experienced volatile short activity. After the activity, the stock price went up +6.29% to $9.12. The overall sentiment for AIRG has been Bearish.

What 10 Analyst Ratings Have To Say About Signature Bank

Analysts have provided the following ratings for Signature Bank (NASDAQ:SBNY) within the last quarter:

Where Atlassian Corporation Stands With Analysts

Over the past 3 months, 8 analysts have published their opinion on Atlassian Corporation (NASDAQ:TEAM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

inkl

Read news from The Economist, FT, and more,
with one subscription

What To Know About B. Riley Securities's Downgrade of Bed Bath & Beyond

What To Know About B. Riley Securities's Downgrade of Bed Bath & Beyond

B. Riley Securities downgraded its rating of Bed Bath & Beyond (NASDAQ:BBBY) to Neutral with a price target of $7.00, changing its price target from $17.00 to $7.00. Shares of Bed Bath & Beyond are trading down 3.64% over the last 24 hours, at $6.75 per share.

Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today

Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today

Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.63% on an annualized basis producing an average annual return of 10.11%. Currently, Biogen has a market capitalization of $31.20 billion.

Goldman Sachs Upgrades Robinhood Markets: Here's What You Need To Know

Goldman Sachs Upgrades Robinhood Markets: Here's What You Need To Know

Goldman Sachs upgraded its rating of Robinhood Markets (NASDAQ:HOOD) to Neutral with a price target of $9.50, changing its price target from $11.50 to $9.50. Shares of Robinhood Markets are trading up 4.19% over the last 24 hours, at $8.34 per share.

BMO Capital Maintains Outperform Rating for Micron Technology: Here's What You Need To Know

BMO Capital Maintains Outperform Rating for Micron Technology: Here's What You Need To Know

BMO Capital has decided to maintain its Outperform rating of Micron Technology (NASDAQ:MU) and lower its price target from $115.00 to $85.00. Shares of Micron Technology are trading up 2.62% over the last 24 hours, at $59.97 per share.

Primoris Expands Utility Business With Acquisition Of PLH Group

Primoris Expands Utility Business With Acquisition Of PLH Group

Primoris Services Corp (NASDAQ:PRIM) has agreed to acquire PLH Group, Inc. for $470 million in cash. PLH Group is a utility-focused specialty construction company with a concentration in key fast-growing regions of the U.S. This transaction doubles the Power Delivery business and increases PRIM's Utilities segment to over 50% of pro forma revenue.…

Check Out What Whales Are Doing With WBD

Check Out What Whales Are Doing With WBD

A whale with a lot of money to spend has taken a noticeably bullish stance on Warner Bros.Discovery. Looking at options history for Warner Bros.Discovery (NASDAQ:WBD) we detected 17 strange trades.

Why This Analyst Says It's 'Simply A Good Time To Buy' Simply Good Foods

Why This Analyst Says It's 'Simply A Good Time To Buy' Simply Good Foods

The recent pullback in Simply Good Foods Co.’s (NASDAQ: SMPL) shares offers “an attractive entry point” into a company offering stable growth in a volatile market, according to Stephens.

Get all your
news in one place.

100's of premium titles.
One news app.

What 7 Analyst Ratings Have To Say About Tractor Supply

Within the last quarter, Tractor Supply (NASDAQ:TSCO) has observed the following analyst ratings:

9 Analysts Have This to Say About Ollie's Bargain Outlet

Over the past 3 months, 9 analysts have published their opinion on Ollie's Bargain Outlet (NASDAQ:OLLI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Expert Ratings for MarketAxess Holdings

MarketAxess Holdings (NASDAQ:MKTX) has observed the following analyst ratings within the last quarter:

WM Technology And Compass Diversified Both Join Russell 2000 And 3000 Indexes

WM Technology, Inc. (NASDAQ: MAPS) has been added to the Russell 3000, Russell 2000 and Russell Microcap indexes and Compass Diversified (NYSE: CODI) has been added to the Russell 2000 and 3000 in

Get all your
news in one place.

100's of premium titles.
One news app.

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies

Here's a roundup of top developments in the biotech space over the last 24 hours:

Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical

Axsome Therapeutics Inc (NASDAQ: AXSM) shares rallied 40% on Monday morning after the company received some positive news from the U.S. Food and Drug Administration regarding its AXS-05 novel treatment for MDD (depression).

Artelo Biosciences Reveals Positive Pre-Clinical Results Of ART26.12, A Novel FABP5 Inhibitor, In Alleviating Chemotherapy-Induced Pain

Professor Saoirse O’Sullivan, vice president of translational sciences at Artelo Biosciences Inc., (NASDAQ: ARTL) presented new research results entitled, “Discovery and pre

Alec Baldwin To Interview Woody Allen On Instagram: What You Need To Know

Alec Baldwin is taking on the role of interviewer with actor/filmmaker Woody Allen, which will be presented on June 28 at 10:30 a.m. EDT on Baldwin’s Instagram page.

Greenlane Secures $5.4M Via Registered Direct Offering

Greenlane Holdings, Inc. (NASDAQ: GNLN) has entered into a definitive agreement with a single institutional investor, for the purchase and sale of 21.6 million shares of its common stock and warrants to purchase 21.6 million shares of common stock at a purchase price per share of $0

Analyst Ratings for Texas Roadhouse

Analysts have provided the following ratings for Texas Roadhouse (NASDAQ:TXRH) within the last quarter:

Preview: Cognyte Software's Earnings

Cognyte Software (NASDAQ:CGNT) is set to give its latest quarterly earnings report on Tuesday, 2022-06-28. Here's what investors need to know before the announcement. Analysts estimate that Cognyte Software will report an earnings per share (EPS) of $0.10.

1 … 361 362 363 364

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Micron Technology

Bed, Bath & Beyond

Robinhood Markets

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

362,621 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play